SURG (Surgepays) Research & Development: $0.00 Mil (TTM As of Mar. 2026)


SURG Surgepays Inc SURG
31 GF Score
Price $0.37
GF Value $1.43
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Surgepays Research & Development?

Surgepays SURG -2.63% 31 Research & Development is $0.00 Mil as of Mar. 2026. GuruFocus rates SURG with a GF Score™ of 31/100 and a GF Value™ of $1.43 (Possible Value Trap). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Surgepays's Research & Development for the three months ended in Mar. 2026 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00 Mil.

Surgepays  (NAS:SURG) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Surgepays Research & Development Related Terms

Surgepays Research & Development Historical Data

* Premium members only.

The historical data trend for Surgepays's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Surgepays Research & Development Chart

Surgepays Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Surgepays Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SURG
31GF Score
Surgepays Inc SURG
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Surgepays Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Surgepays (SURG) has a Research & Development of $0.00 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Surgepays and its competitors.
Is Surgepays' Research & Development too high?
Surgepays' current Research & Development is $0.00 Mil. Overall, Surgepays has a GF Score™ of 31/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Surgepays' Research & Development compare to HMMR and ATGN?
Surgepays' Research & Development of $0.00 Mil can be compared against companies in the Telecommunication Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Telecommunication Services company?
A good Research & Development depends on the Telecommunication Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Surgepays and its competitors. Surgepays's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgepays stock overvalued right now?
Based on GuruFocus' analysis, Surgepays (SURG) is currently considered Possible Value Trap. The stock's GF Value™ is $1.43, compared to a current price of $0.37 — trading 74.1% below its estimated fair value. The current Research & Development is $0.00 Mil. Surgepays' overall GF Score™ is 31/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Surgepays (SURG), the current Research & Development is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Surgepays (SURG) Overvalued in 2026?

Based on GuruFocus' analysis, Surgepays stock appears to be undervalued. The current stock price of $0.37 is trading 74.1% below its estimated GF Value™ of $1.43. GuruFocus considers Surgepays to be Possible Value Trap.

Key valuation signals for SURG:

  • Research & Development: $0.00 Mil
  • GF Value™: $1.43 vs. price of $0.37 (74.1% below fair value)
  • GF Score™: 31/100 with 5 warning signs

No single metric tells the full story. See the SURG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Surgepays Business Description

Other Exchanges 9B90:Germany
Address 3124 Brother Boulevard, Suite 104, Bartlett, TN, USA, 38133
Surgepays Inc is a wireless and point of sale technology company focused on serving underserved and value-conscious consumers through a combination of retail distribution and digital acquisition channels. It provides mobile connectivity, financial technology services, and transaction processing solutions through an integrated platform that combines wireless services with point of sale software and retail distribution. It enables in-store and online activation of wireless services, prepaid top-ups, and financial transactions, allowing consumers to access essential services in both local and digital environments. Its segments are wireless services or MVNO Telecommunications, platform services or MVNE Enablement Platform (HERO), and wholesale enablement or Comprehensive Platform Services.
31GF Score

Get the complete analysis for SURG

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.37
Price
$1.43
GF Value